PATH MER Indicators, published by PATH. This is not an authorized publication; it is the continuous build for version 0.1.0). This version is based on the current content of https://github.com/PATH-Global-Health/MERindicators and changes regularly. See the Directory of published versions
Draft as of 2023-10-19 |
{
"resourceType" : "CodeSystem",
"id" : "DAKICD11",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-insensitive code system <code>http://hl7.org/fhir/sid/icd-11</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">1C62.0<a name=\"DAKICD11-1C62.460\"> </a></td><td>HIV disease clinical stage 1 without mention of tuberculosis or malaria</td></tr><tr><td style=\"white-space:nowrap\">1C62.1<a name=\"DAKICD11-1C62.461\"> </a></td><td>HIV disease clinical stage 2 without mention of tuberculosis or malaria</td></tr><tr><td style=\"white-space:nowrap\">1C62.2<a name=\"DAKICD11-1C62.462\"> </a></td><td>HIV disease clinical stage 3 without mention of tuberculosis or malaria</td></tr><tr><td style=\"white-space:nowrap\">1C62.3<a name=\"DAKICD11-1C62.463\"> </a></td><td>HIV disease clinical stage 4 without mention of tuberculosis or malaria</td></tr><tr><td style=\"white-space:nowrap\">1C62.Z<a name=\"DAKICD11-1C62.46Z\"> </a></td><td>Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified</td></tr><tr><td style=\"white-space:nowrap\">XM63K0<a name=\"DAKICD11-XM63K0\"> </a></td><td>Anti-infective antiviral</td></tr><tr><td style=\"white-space:nowrap\">QA14<a name=\"DAKICD11-QA14\"> </a></td><td>Contact with health services for human immunodeficiency virus counselling</td></tr><tr><td style=\"white-space:nowrap\">XM35P4<a name=\"DAKICD11-XM35P4\"> </a></td><td>Abacavir</td></tr><tr><td style=\"white-space:nowrap\">XM2L06<a name=\"DAKICD11-XM2L06\"> </a></td><td>Emtricitabine</td></tr><tr><td style=\"white-space:nowrap\">XM5471<a name=\"DAKICD11-XM5471\"> </a></td><td>Lamivudine</td></tr><tr><td style=\"white-space:nowrap\">XM9C07<a name=\"DAKICD11-XM9C07\"> </a></td><td>Zidovudine</td></tr><tr><td style=\"white-space:nowrap\">XM8Z78<a name=\"DAKICD11-XM8Z78\"> </a></td><td>Didanosine</td></tr><tr><td style=\"white-space:nowrap\">XM7RM1<a name=\"DAKICD11-XM7RM1\"> </a></td><td>Stavudine</td></tr><tr><td style=\"white-space:nowrap\">XM67N3<a name=\"DAKICD11-XM67N3\"> </a></td><td>Tenofovir disoproxil</td></tr><tr><td style=\"white-space:nowrap\">XM1DX2<a name=\"DAKICD11-XM1DX2\"> </a></td><td>Efavirenz</td></tr><tr><td style=\"white-space:nowrap\">XM7N44<a name=\"DAKICD11-XM7N44\"> </a></td><td>Etravirine</td></tr><tr><td style=\"white-space:nowrap\">XM10T5<a name=\"DAKICD11-XM10T5\"> </a></td><td>Nevirapine</td></tr><tr><td style=\"white-space:nowrap\">XM1KD4<a name=\"DAKICD11-XM1KD4\"> </a></td><td>Rilpivirine</td></tr><tr><td style=\"white-space:nowrap\">XM4TF3<a name=\"DAKICD11-XM4TF3\"> </a></td><td>Atazanavir and Ritonavir</td></tr><tr><td style=\"white-space:nowrap\">XM3EH7<a name=\"DAKICD11-XM3EH7\"> </a></td><td>Lopinavir and Ritonavir</td></tr><tr><td style=\"white-space:nowrap\">XM8ZN1<a name=\"DAKICD11-XM8ZN1\"> </a></td><td>Darunavir and Ritonavir</td></tr><tr><td style=\"white-space:nowrap\">XM56L1<a name=\"DAKICD11-XM56L1\"> </a></td><td>Ritonavir</td></tr><tr><td style=\"white-space:nowrap\">XM6K45<a name=\"DAKICD11-XM6K45\"> </a></td><td>Dolutegravir</td></tr><tr><td style=\"white-space:nowrap\">XM82D3<a name=\"DAKICD11-XM82D3\"> </a></td><td>Raltegravir</td></tr><tr><td style=\"white-space:nowrap\">XM8QY9<a name=\"DAKICD11-XM8QY9\"> </a></td><td>Lamivudine, Tenofovir disoproxil and Dolutegravir</td></tr><tr><td style=\"white-space:nowrap\">XM3U67<a name=\"DAKICD11-XM3U67\"> </a></td><td>Antivirals for treatment of human immunodeficiency virus infections, combinations best fit</td></tr><tr><td style=\"white-space:nowrap\">XM9NL2<a name=\"DAKICD11-XM9NL2\"> </a></td><td>Lamivudine, Tenofovir disoproxil and Efavirenz</td></tr><tr><td style=\"white-space:nowrap\">XM2UU9<a name=\"DAKICD11-XM2UU9\"> </a></td><td>Lamivudine, Abacavir and Dolutegravir</td></tr></table></div>"
},
"url" : "http://hl7.org/fhir/sid/icd-11",
"version" : "0.1.0",
"name" : "DAKICD11",
"title" : "ICD-11 codes from the HIV DAK",
"status" : "draft",
"experimental" : false,
"date" : "2023-10-19T20:59:19+00:00",
"publisher" : "PATH",
"contact" : [
{
"name" : "PATH",
"telecom" : [
{
"system" : "url",
"value" : "https://www.path.org"
},
{
"system" : "email",
"value" : "info@path.org"
}
]
},
{
"name" : "PATH",
"telecom" : [
{
"system" : "email",
"value" : "info@path.org",
"use" : "work"
}
]
}
],
"description" : "ICD-11 codes from the HIV DAK",
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "001",
"display" : "World"
}
]
}
],
"caseSensitive" : false,
"content" : "complete",
"count" : 28,
"concept" : [
{
"code" : "1C62.0",
"display" : "HIV disease clinical stage 1 without mention of tuberculosis or malaria"
},
{
"code" : "1C62.1",
"display" : "HIV disease clinical stage 2 without mention of tuberculosis or malaria"
},
{
"code" : "1C62.2",
"display" : "HIV disease clinical stage 3 without mention of tuberculosis or malaria"
},
{
"code" : "1C62.3",
"display" : "HIV disease clinical stage 4 without mention of tuberculosis or malaria"
},
{
"code" : "1C62.Z",
"display" : "Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified"
},
{
"code" : "XM63K0",
"display" : "Anti-infective antiviral"
},
{
"code" : "QA14",
"display" : "Contact with health services for human immunodeficiency virus counselling"
},
{
"code" : "XM35P4",
"display" : "Abacavir"
},
{
"code" : "XM2L06",
"display" : "Emtricitabine"
},
{
"code" : "XM5471",
"display" : "Lamivudine"
},
{
"code" : "XM9C07",
"display" : "Zidovudine"
},
{
"code" : "XM8Z78",
"display" : "Didanosine"
},
{
"code" : "XM7RM1",
"display" : "Stavudine"
},
{
"code" : "XM67N3",
"display" : "Tenofovir disoproxil"
},
{
"code" : "XM1DX2",
"display" : "Efavirenz"
},
{
"code" : "XM7N44",
"display" : "Etravirine"
},
{
"code" : "XM10T5",
"display" : "Nevirapine"
},
{
"code" : "XM1KD4",
"display" : "Rilpivirine"
},
{
"code" : "XM4TF3",
"display" : "Atazanavir and Ritonavir"
},
{
"code" : "XM3EH7",
"display" : "Lopinavir and Ritonavir"
},
{
"code" : "XM8ZN1",
"display" : "Darunavir and Ritonavir"
},
{
"code" : "XM56L1",
"display" : "Ritonavir"
},
{
"code" : "XM6K45",
"display" : "Dolutegravir"
},
{
"code" : "XM82D3",
"display" : "Raltegravir"
},
{
"code" : "XM8QY9",
"display" : "Lamivudine, Tenofovir disoproxil and Dolutegravir"
},
{
"code" : "XM3U67",
"display" : "Antivirals for treatment of human immunodeficiency virus infections, combinations best fit"
},
{
"code" : "XM9NL2",
"display" : "Lamivudine, Tenofovir disoproxil and Efavirenz"
},
{
"code" : "XM2UU9",
"display" : "Lamivudine, Abacavir and Dolutegravir"
}
]
}
IG © 2023+ PATH. Package path.merindicators#0.1.0 based on FHIR 4.0.1. Generated 2023-10-19
Links: Table of Contents |
QA Report |
Version History |
|